Aspen expands revenue-boosting therapeutic unit with new $80 million plant

PORT ELIZABETH, South Africa (Reuters) - South African drug maker Aspen Pharmacare will produce up to 3.6 billion pills a year at its new manufacturing plant as it expands its therapeutic portfolio, Chief Executive Stephen Saad said on Monday at the official launch.